About the Genotypic Prevention Session
Contrarily, genotypic prevention refers to actions taken to prevent the passing on of certain genotypes to the next generation, such as selective termination after prenatal diagnosis. Genotypic prevention is either carried out on behalf of a future parent (or two) as a method of lowering the likelihood of pregnancy, or it is carried out as a public health measure to lower the prevalence of a disease in the general populace. When germline gene editing is considered as an intervention on the gametes of potential parents prior to conception, the preventative objective of this technology becomes even more evident. Instead than focusing on a specific patient's display of pathological symptoms, the aim is to prevent the "vertical transmission" of harmful genes within families.
Topics Covered in Genotypic Prevention
Preconception genetic risk assessment
Prenatal diagnosis and reproductive counselling
Carrier screening in at-risk families
Preimplantation genetic testing and selection
Germline editing and inherited disease prevention
Ethics of preventing vertical genetic transmission
Featured Speakers — Genotypic Prevention 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Genotypic Prevention Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IPHC 2027
Why Attend the Genotypic Prevention Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Genotypic Prevention work, reviewed by the scientific committee.
Network Globally
Meet public health researchers, educators, and policy leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Genotypic Prevention research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IPHC 2027 for the Genotypic Prevention track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Genotypic Prevention Conference 2027 — FAQs
What is the Genotypic Prevention track at IPHC 2027?
The Genotypic Prevention track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Genotypic Prevention. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Genotypic Prevention sessions?
Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Genotypic Prevention are all welcome — whether presenting or attending.
Can I present my research in the Genotypic Prevention track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Genotypic Prevention sessions?
Yes. IPHC 2027 is a hybrid conference — attend the Genotypic Prevention track in person in Singapore or join live online, with on-demand access afterward.
Join the IPHC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.